![]() |
Technical Data
Media
|
|
Tryptose Blood Agar Base (Powder)
T9055
Microbiological Grade
Storage RT Shipping RT
|
Components shown as g/L
|
||||||||||
|
A general purpose blood agar base medium. Appearance: Light beige powder, homogeneous, free flowing. Solubility: Yellow to light beige, turbid, incomplete. Note: Agar will dissolve upon heating. pH: 7.2±0.2 Cultural Response: The medium was prepared according to the directions with 5% sheep blood and inoculated with the organisms listed below (10-300cfu). Cultures were incubated aerobically at 35±2°C and examined for growth at 18-24 hours. Escherichia coli ATCC 25922 Staphylococcus aureus ATC 25923 Streptococcus pneumoniae ATC 6305 Streptococcus pyogenes ATC 19615 Growth Hemolysis Excellent --- Excellent Beta Hemolysis Excellent Alpha Hemolysis Excellent Beta Hemolysis Country of Origin: The raw animal product used in the manufacturing of Tryptose Blood Agar Base is derived from casein originating in the USA, New Zealand and/or Australia where there have been no reported cases of bovine spongiform encephalopathy (BSE). During processing of the raw material, a batch is heated to a minimum of 80°C for 1 hour including a minimum of 5 minutes at 105°C. The product is then dried at a minimum of 140°C. Directions per Liter: Dissolve 33 grams in 800-900ml of ddH2O stirring gently with heating with frequent agitation and boil for 1 min. to completely dissolve. Add additional water to bring the solution to1L. Dispense into appropriate containers, loosen caps and autoclave for 15 minutes at 121ºC (15psi). Prepare 5-10% blood agar by aseptically adding the appropriate volume of sterile, defibrinated blood to melted, sterile agar medium, cooled to 45-50°C. Storage and Stability: Store powdered media at RT. Opened bottles should be capped tightly and kept in a dark, low humidity environment. Prepared media should be kept refrigerated and used within a short period of time. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|||||||||||
|
US Biological application reference: Graham, J.P. et al., (2009) Environmental Research 109:682-689. |